Jan 08, 2018
Livongo and Lilly Collaborate on Real-World Diabetes Research
Dec 14, 2017
Rimidi and Lilly Collaborate to Personalize Solutions for People Using Insulin
Dec 08, 2017
Lilly Reports Top-Line Results from CYRAMZA® (ramucirumab) Phase 3 Study in First-Line Advanced Gastric Cancer
Dec 05, 2017
Lilly Initiates Clinical Trial to Evaluate the Functionality and Safety of its Automated Insulin Delivery System
Oct 12, 2017
FDA Grants Priority Review for Potential New Indication for Lilly's Verzenio(TM) (abemaciclib) as Initial Treatment of Advanced Breast Cancer
Oct 10, 2017
Lilly Reports Topline Results from Phase 3 JUNIPER Trial Evaluating Verzenio(TM) (abemaciclib) in KRAS-Mutated, Advanced Non-Small Cell Lung Cancer
Oct 06, 2017
Lilly MONARCH 3 Study Published in Journal of Clinical Oncology Demonstrates Benefit of Verzenio(TM) (abemaciclib) Plus NSAI in Advanced Breast Cancer
Sep 10, 2017
Lilly Builds Upon Body of Clinical Evidence for CYRAMZA® (ramucirumab) with Phase 3 RANGE Data Demonstrating Superior Progression-Free Survival in Advanced or Metastatic Urothelial Cancer
Jun 27, 2017
Lilly Diabetes Brings an Extra Splash of Summertime Fun and Inspiration to Diabetes Camps with Launch of Annual Camp Care Package Speaker Tour
Jun 03, 2017
Lilly Builds Upon Body of Data for Abemaciclib with Phase 3 MONARCH 2 Data Demonstrating Superior Progression-Free Survival in Advanced Breast Cancer
May 31, 2017
Lilly Announces Phase 3 RANGE Urothelial Cancer Trial of CYRAMZA® (ramucirumab) Met Primary Endpoint, Improving Progression-Free Survival